Results 161 to 170 of about 18,145 (196)

Efficacy and safety of ranibizumab, aflibercept, and conbercept in the treatment of diabetic macular edema: a retrospective comparative study. [PDF]

Sci Rep
Liu B, Qiao Q, Dang Y.
europepmc   +1 more source

Efficacy and Safety of Ranibizumab Combined with Dexamethasone Intravitreal Implant Sequential Therapy for Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusion. [PDF]

Drug Des Devel Ther
Gao L, Cai X, Dang Y.
europepmc   +1 more source

Pachychoroid diseases of the macula: an update. [PDF]

Med Hypothesis Discov Innov Ophthalmol
Kayabasi M, Koksaldi S, Karti O, Saatci AO.   +3 more
europepmc   +1 more source

A meta-analysis of clinical outcomes in diabetic macular edema. [PDF]

Adv Ophthalmol Pract Res
Bobrek CN, Kapoor I, Sarvepalli SM, Timtim E, Hadziahmetovic M.   +4 more
europepmc   +1 more source

Synergistic inhibition of macular vascular permeability in diabetic edema: Ginsenoside Rg3 enhances ranibizumab efficacy by targeting angiopoietin-like protein 4 and vascular endothelial growth factor via neuropilin/RhoA signaling. [PDF]

J Diabetes Investig
Yu J, Li X, Liu Y.
europepmc   +1 more source

Association of vitreous CREG1 with diabetic macular edema response and edema resolution following ranibizumab therapy. [PDF]

Front Med (Lausanne)
Zhu L, Ding D, Xiao H, Cao Y, Li D, Cao G.   +5 more
europepmc   +1 more source

Retinal vein occlusion-related macular edema: An updated review of current evidence and future directions. [PDF]

Indian J Ophthalmol
Temkar S, Rajasekar G, Shah AD, Shaikh N, Deb AK, Basa K.   +5 more
europepmc   +1 more source

Long-Term Management of Polypoidal Choroidal Vasculopathy: A Narrative Review. [PDF]

Ophthalmol Ther
Koh A, Staurenghi G, Chhablani J, Panos GD, Tan CS, Yamaguchi TCN, Empeslidis T.   +6 more
europepmc   +1 more source